India rejects patent on Pfizer’s arthritis drug

“The invention disclosed and claimed in the instant application … is not considered as an invention under the provisions of the Act,” Bharat NS, an assistant controller at the patent office, wrote in an order dated 3 September. Pfizer is reviewing its …
invention – read more